News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Avita Medical Initiates FDA Study of Its ReCell® Spray-On-Skin™ for Reconstructive and Aesthetic Indications



5/16/2012 10:50:08 AM

NORTHRIDGE, Calif. & CAMBRIDGE, England--(BUSINESS WIRE)--Avita Medical Ltd. (ASX: AVH), (OTC: AVMXF), (OTCQX: AVMXY),the regenerative medicine company, today announced that it has commenced enrolment in the US FDA-approved feasibility study for the use of ReCell® Spray-On-Skin™ in the treatment of hypertrophic dyspigmented scars (raised and/or discoloured scars).

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES